See every side of every news story
Published loading...Updated

SecondWave Systems raises $7M Series A to Accelerate Clinical Development of a Novel Ultrasound-Based Anti-Inflammatory Therapy

  • SecondWave Systems, Inc., a St. Paul company, finalized a $7 million Series A funding on April 8, 2025.
  • SecondWave requires funding to advance its novel ultrasound-based treatment for inflammatory disorders into clinical studies.
  • Treo Ventures and a healthcare strategic led the financing, alongside Scientific Health Development, and University of Minnesota's Discovery Capital.
  • CEO Anuj Bhardwaj stated the company is excited to enter the next phase of development with new investor partners.
  • SecondWave will use the funds to support its next clinical study, expanding on positive results from their first study.
Insights by Ground AI
Does this summary seem wrong?

24 Articles

All
Left
Center
10
Right
journal-republican.comjournal-republican.com
+21 Reposted by 21 other sources
Center

SecondWave Systems raises $7M Series A to Accelerate Clinical Development of a Novel Ultrasound-Based Anti-Inflammatory Therapy

ST. PAUL, Minn., April 8, 2025 /PRNewswire/ -- SecondWave Systems, Inc., a clinical stage medical device company developing a novel ultrasound-based treatment for inflammatory disorders, announced today that it has closed a $7M Series A financing round. The financing was…

·Monticello, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

KWWL broke the news in Waterloo, United States on Tuesday, April 8, 2025.
Sources are mostly out of (0)

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.